Diabetes Technology — Panacea Meets Reality
La Nouvelle Orleans Ballroom B
Level 2, Ernest N. Morial Convention Center
Q&A with Anne Peters, MD
Professor of Clinical Medicine,
University of Southern California
What is your presentation about?
Diabetes technology has been advancing and has changed the world for many people with diabetes. However, many under-resourced patients lack access to it and even with technology we are not able to get the majority of people to an A1C of <7% or eliminate episodes of severe hypoglycemia. Therefore, much work needs to be done to improve health equity and improve outcomes for all people with T1D.
What makes this topic important in 2022?
COVID has magnified health care disparities and the risks associated with poorly controlled diabetes. We have to do better for those who have less.
How did you become involved with this area of diabetes research or care?
I have spent my entire life devoted to treating people with diabetes and in particular in under-resourced communities. I have tried to provide care to those with the greatest need.
What are you most looking forward to at the 82nd Scientific Sessions?
Hearing the updates from various clinical trials and learning how others approach clinical patient care in a variety of disparate settings.
[sub-post-content]